Detalhe da pesquisa
1.
Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region.
Am J Hum Genet
; 90(3): 434-44, 2012 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22387017
2.
Asymmetric homoenolate additions to acyl phosphonates through rational design of a tailored N-heterocyclic carbene catalyst.
J Am Chem Soc
; 136(1): 76-9, 2014 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24299299
3.
Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset.
Neurogenetics
; 14(3-4): 173-9, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23644918
4.
Enantioselective N-heterocyclic carbene catalyzed annulation reactions with imidazolidinones.
Angew Chem Int Ed Engl
; 52(51): 13616-20, 2013 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24249661
5.
A Phenotypic Atlas for Huntington Disease Based on Data From the Enroll-HD Cohort Study.
Neurol Genet
; 9(6): e200111, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38035176
6.
Expanding the Allelic Heterogeneity of ANO10-Associated Autosomal Recessive Cerebellar Ataxia.
Neurol Genet
; 9(1): e200051, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36698452
7.
Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset.
Hum Genet
; 131(12): 1833-40, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22825315
8.
TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease.
Biochem Biophys Res Commun
; 424(3): 404-8, 2012 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22771793
9.
Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses.
Acta Neuropathol
; 120(6): 777-88, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20821223
10.
Late Onset Huntington Disease: Phenotypic and Genotypic Characteristics of 10 Cases in Argentina.
J Huntingtons Dis
; 8(2): 195-198, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31045517
11.
Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial.
Neurology
; 92(14): e1643-e1651, 2019 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30850442
12.
End of life: Expert care and support, not physician-hastened death.
Neurology
; 93(17): 729-734, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31530709
13.
Scientific, Ethical, and Practical Considerations for the Testing and Disclosure of Alzheimer Disease Biomarkers.
Neurology
; 100(21): 993-994, 2023 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36792374
14.
Isolated Craniocervical Dystonia Without Initial Neuropsychiatric Manifestations Associated with NMDA-Receptor Antibodies.
Mov Disord Clin Pract
; 10(4): 680-682, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37070040
15.
Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic Testing.
Tremor Other Hyperkinet Mov (N Y)
; 7: 467, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28975045
16.
Medical management of motor manifestations of Huntington disease.
Handb Clin Neurol
; 144: 141-150, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28947112
17.
What do we know about Late Onset Huntington's Disease?
J Huntingtons Dis
; 6(2): 95-103, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28671137
18.
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.
Neurology
; 88(2): 152-159, 2017 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27913695
19.
Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study.
BMC Med Genet
; 7: 71, 2006 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-16914060
20.
Very early-onset frontotemporal dementia with no family history predicts underlying fused in sarcoma pathology.
Brain
; 133(Pt 12): e158; author reply e159, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20693541